A citation-based method for searching scientific literature

E De Pablo-Fernandez, F Sierra-Hidalgo, J Benito-León, F Bermejo-Pareja. Acta Neurol Scand 2017
Times Cited: 35



Eva Schernhammer, Johnni Hansen, Kathrine Rugbjerg, Lene Wermuth, Beate Ritz. Diabetes Care 2011
Times Cited: 117




List of shared articles



Times cited

α-Synuclein Regulates Peripheral Insulin Secretion and Glucose Transport.
Nadeeja Wijesekara, Rosemary Ahrens, Ling Wu, Tammy Langman, Anurag Tandon, Paul E Fraser. Front Aging Neurosci 2021
3


Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson's Disease: A Systematic Review.
Fauze Camargo Maluf, David Feder, Alzira Alves de Siqueira Carvalho. Parkinsons Dis 2019
21

Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression.
Harneek Chohan, Konstantin Senkevich, Radhika K Patel, Jonathan P Bestwick, Benjamin M Jacobs, Sara Bandres Ciga, Ziv Gan-Or, Alastair J Noyce. Mov Disord 2021
19

Diabetes, insulin and new therapeutic strategies for Parkinson's disease: Focus on glucagon-like peptide-1 receptor agonists.
Carmen M Labandeira, Arturo Fraga-Bau, David Arias Ron, Ana Muñoz, Gema Alonso-Losada, Antonio Koukoulis, Jesus Romero-Lopez, Ana I Rodriguez-Perez. Front Neuroendocrinol 2021
5

The Association Between Type 2 Diabetes Mellitus and Parkinson's Disease.
Julia L Y Cheong, Eduardo de Pablo-Fernandez, Thomas Foltynie, Alastair J Noyce. J Parkinsons Dis 2020
33

Diabetes mellitus and Parkinson's disease: dangerous liaisons between insulin and dopamine.
Angela De Iuliis, Ennio Montinaro, Giuseppe Fatati, Mario Plebani, Carlo Colosimo. Neural Regen Res 2022
1

Diabetes Mellitus and Parkinson's Disease: A Systematic Review and Meta-Analyses.
Klara Komici, Grazia Daniela Femminella, Leonardo Bencivenga, Giuseppe Rengo, Gennaro Pagano. J Parkinsons Dis 2021
1

Diabetic retinopathy as a potential marker of Parkinson's disease: a register-based cohort study.
Maria E C Larsen, Anne S Thykjaer, Frederik N Pedersen, Sören Möller, Caroline S Laugesen, Nis Andersen, Jens Andresen, Javad Hajari, Steffen Heegaard, Kurt Højlund,[...]. Brain Commun 2021
1

Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease.
Dilan Athauda, Thomas Foltynie. Neuropharmacology 2018
49

Fasting plasma glucose variability in midlife and risk of Parkinson's disease: A nationwide population-based study.
H S Chung, J S Lee, J A Kim, E Roh, Y-B Lee, S-H Hong, J H Yu, N H Kim, H J Yoo, J A Seo,[...]. Diabetes Metab 2021
6